Dr. Felicia Hsu is a physician, engineer and investor at BOLD Capital Partners, who studied Biomedical Engineering at MIT before obtaining her M.D. from Harvard Medical School. Her work on medical breakthroughs––from melanoma detection devices to nanoparticle drug delivery systems for pancreatic cancer––have been featured in peer-reviewed Oncology journals. She’s working on her debut book, a narrative memoir of her journey as an Asian American physician fighting the COVID-19 pandemic on the frontlines, and advocating for her father with his diagnosis of pancreatic cancer. As an advocate for women entrepreneurs, Felicia is helping support Harvard SheSolves and is an executive for a SoCal female founders society. In her spare time, she volunteers as a hospital advocate and sexual violence crisis hotline responder.